Viewing Study NCT03242967

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:35 AM
Ignite Modification Date: 2026-02-20 @ 2:46 PM
Study NCT ID: NCT03242967
Status: WITHDRAWN
Last Update Posted: 2018-11-05
First Post: 2017-08-04
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Study to Evaluate Three Times Per Week (TIW) Oral Dosing of Vadadustat for Anemia in Subjects With Dialysis-Dependent Chronic Kidney Disease (DD-CKD)
Sponsor: Akebia Therapeutics
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Anemia View
None Dialysis-Dependent Chronic Kidney Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Anemia View
None hemoglobin View
None darbepoetin alfa View
None TIW View
None hypoxia-inducible factor prolyl-hydroxylase inhibitor View
None HIF-PHI View
None AKB-6548 View
None vadadustat View
None renal View
None hypoxia-inducible factor View
None HIF View
None dialysis-dependent chronic kidney disease View
None CKD View
None DD-CKD View
None kidney View
None erythropoiesis stimulating agent View
None ESA View